Table 2 Distribution of HR-HPV types in cervical cancer patients
From: Independent prognostic role of human papillomavirus genotype in cervical cancer
HR-HPV typea | Species | SCCb (NÂ =Â 296) | AC/ASCc (NÂ =Â 10) | Total (%) | |
|---|---|---|---|---|---|
Single infection | Â | Â | Â | Â | 268 (87.58) |
| Â | 16 | alpha-9 | 184 | 2 | 186 (60.78) |
| Â | 18 | alpha-7 | 24 | 3 | 27 (8.82) |
| Â | 52 | alpha-9 | 17 | 1 | 18 (5.88) |
| Â | 39 | alpha-7 | 8 | 0 | 8 (2.61) |
| Â | 33 | alpha-9 | 6 | 0 | 6 (1.96) |
| Â | 31 | alpha-9 | 5 | 0 | 5 (1.63) |
| Â | 58 | alpha-9 | 4 | 1 | 5 (1.63) |
| Â | 59 | alpha-7 | 4 | 0 | 4 (1.31) |
| Â | 68 | alpha-7 | 4 | 0 | 4 (1.31) |
| Â | 45 | alpha-7 | 3 | 0 | 3 (0.98) |
| Â | 51 | alpha-5 | 1 | 0 | 1 (0.33) |
| Â | 56 | alpha-10 | 1 | 0 | 1 (0.33) |
Multiple infection | Â | Â | 35 | 3 | 38 (12.42) |
Alpha-7 only | Â | Â | 43 | 3 | 46 (15.03) |
Alpha-9 only | Â | Â | 237 | 4 | 241 (78.76) |